An Open-Label, 8-week Trial of Bupropion Hydrochloride Extended Release (Wellbutrin XL) In Patients With Major Depressive Disorder (MDD) With Atypical Features.
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2011
At a glance
- Drugs Bupropion (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 26 Nov 2011 New trial record